Clinical Masterclass 2022
|
0:00:00 |
Introduction |
Peter Psaltis |
|
0:02:12 |
Case study #1 |
Sandhya Ramakrishna |
|
0:13:12 |
What should we do about the LDL-C and how? |
David Sullivan |
|
0:33:42 |
The potential of intensively lowering LDL-C in people with PAD |
Jonathan Golledge |
|
0:43:15 |
Should we screen for FH and test for Lp(a)? |
Gerald Watts |
|
0:54:44 |
Discussion |
|
|
1:11:38 |
Obesity and Diabetes: What’s new? |
Elif Ekinci |
|
1:41:39 |
Triglycerides – to treat or not to treat? |
Len Kritharides |
|
2:02:00 |
Panel Discussion |
|
|
0:00:00 |
Introduction – Judy de Haan |
|
|
0:00:22 |
Overview: Inflammation |
Kate Schroder |
|
0:31:30 |
Colchicine |
Sanjay Patel |
|
0:49:18 |
PET measurements of inflammatory atherosclerosis |
Giresh Dwivedi |
|
1:10:02 |
Clonal Haematopoiesis |
Peter Psaltis |
|
1:31:50 |
Discussion |
|
|
0:00:00 |
Introduction |
Richard O’Brien |
|
0:00:46 |
Changing trends in the obesity epidemic |
Caroline Miller |
|
0:21:44 |
GLP1 – CV Outcomes |
Jonathan Shaw |
|
0:36:32 |
SGLT2 Inhibitors – CV Outcomes |
Samantha Hocking |
|
0:51:28 |
Discussion |
|
|
0:00:00 |
Introduction |
Sophia Zoungas |
|
0:00:30 |
Polygenic Risk/Genomics |
Pradeep Natarajan |
|
0:30:18 |
Non-Alcoholic Fatty Liver Disease |
Catherine Croagh |
|
0:46:30 |
Chronic Kidney Disease |
Carol Pollock |
|
1:02:50 |
Stroke/COMPASS |
Vincent Thijs |
|
1:22:50 |
Discussion |
|
|
0:00:00 |
Introduction |
Natalie Ward |
|
0:00:24 |
LPa |
Karam Kostner |
|
0:13:40 |
PCSK9 what is left to answer? |
Steve Nicholls |
|
0:29:54 |
Omega 3 fatty acids |
Trevor Mori |
|
1:06:43 |
Concluding remarks |
David Sullivan |